WASHINGTON, Dec 29 (Reuters) - Approval of a third COVID-19
vaccine dose for U.S. children aged 12-15 could be days or weeks
away, the head of the Centers for Disease Control and Prevention
(CDC) told CNN in an interview on Wednesday.
Asked when children in that age group could be eligible to
receive a booster shot, CDC Director Rochelle Walensky said: "So
the FDA (Food and Drug Administration) is looking at that right
now. Of course, the CDC will swiftly follow as soon as we hear
from them, and I'm hoping to have that in the days to weeks
ahead."
It was not immediately clear, however, that Pfizer Inc
PFE.N and its partner, BioNTech SE 22UAy.DE -- the only
manufacturer whose COVID-19 vaccine is approved for kids -- has
formally filed for FDA approval for a booster dose in children
ages 12-15.
U.S. children ages 16 and 17 are eligible for a third
booster shot. urn:newsml:reuters.com:*:nL1N2SU1ML
(Reporting by Susan Heavey; Editing by Mark Porter)
((sheavey@thomsonreuters.com; +1-202-898-8300;))